CD180 and Its Role in Glioma Survival
Author Information
Author(s): Wang Wen, Li Junsheng, He Qiheng, Liu Chenglong, Zheng Zhiyao, Zhang Bojian, Mou Siqi, Sun Wei, Zhao Jizong
Primary Institution: Beijing Tiantan Hospital, Capital Medical University
Hypothesis
The study investigates the role of CD180-overexpressing macrophages in glioma progression and patient survival.
Conclusion
High CD180 expression in glioma is associated with poor prognosis and promotes malignant behaviors in glioma cells.
Supporting Evidence
- CD180 was significantly upregulated in glioma samples and associated with poor prognosis.
- High CD180 expression correlated with increased immune cell infiltration and elevated levels of immune checkpoints.
- In vitro experiments showed that CD180-overexpression macrophages promoted glioma cell proliferation and invasion.
Takeaway
This study found that a protein called CD180 makes brain tumors grow faster and helps them avoid the immune system, which is not good for patients.
Methodology
The study used RNA-seq data, immune infiltration analysis, and various in vitro assays to evaluate the effects of CD180 on glioma cells.
Potential Biases
Potential biases due to reliance on retrospective data and the limitations of in vitro models.
Limitations
The study relied on retrospective analyses and in vitro models, which may not fully replicate the complexity of glioma.
Participant Demographics
The study analyzed data from glioma patients, but specific demographic details were not provided.
Statistical Information
P-Value
0.026
Confidence Interval
95%CI=1.046–2.020
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website